Fulgent Genetics Stock: Post-Pandemic Devaluing Appears Overdone (NASDAQ:FLGT)


ebrublue10/iStock via Getty Images

Company Overview

Established in 2011, Fulgent Genetics (NASDAQ:FLGT) is a technology-driven organization dedicated to clinical diagnostic and therapeutic advancements. The diagnostic branch of the company provides a wide range of molecular and genetic testing services

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *